Enhancement of Epidermal Growth Factor Receptor-Degradation Pathway in Acquired Gefitinib-Resistant Human Non-Small Cell Lung Cancer Cell Lines

The Showa University Journal of Medical Sciences
doi 10.15369/sujms1989.16.147
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Showa University Society

Related search

Autophagic Degradation of Epidermal Growth Factor Receptor in Gefitinib-Resistant Lung Cancer by Celastrol

International Journal of Oncology
Cancer ResearchOncology
2016English

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib

Yearbook of Pulmonary Disease
2006English

Morphine-Induced Epidermal Growth Factor Pathway Activation in Non–Small Cell Lung Cancer

Anesthesia and Analgesia
AnesthesiologyPain Medicine
2011English

The Role of Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer

Dicle Medical Journal / Dicle Tip Dergisi
2015English

Screening Circular RNAs Related to Acquired Gefitinib Resistance in Non-Small Cell Lung Cancer Cell Lines

Journal of Cancer
Oncology
2020English

OA14 Phase 2 Study: Tepotinib + Gefitinib in MET+/Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Somatic Mutations of the Epidermal Growth Factor Receptor and Non-Small-Cell Lung Cancer

Journal of Medical Genetics
Genetics
2006English

Management of Brain Metastases in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy